Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Iranian Journal of Neurology|March 20, 2019
Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysisAmir Hashemi-Meshkini, Hedieh Sadat Zekri, Hasan Karimi-Yazdi, et al.Journal of Research in Pharmacy Practice|May 11, 2016
Developing a patient satisfaction questionnaire for services provided in Iranian community pharmaciesSaeed Yaghoubifard, Arash Rashidian, Abbas Kebriaeezadeh, et al.Medical Journal of the Islamic Republic of Iran|July 9, 2016
Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysisZahra Kavosi, Maryam Sarikhani Khorrami, Khosro Keshavarz, et al.Cost Effectiveness and Resource Allocation : C/E|January 26, 2023
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysisZahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, et al.The Journal of Tehran Heart Center|August 28, 2023
Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in IranAmir Hashemi-Meshkini, Amirmohammad Tajik, Nayyereh Ayati, et al.Value in Health Regional Issues|June 27, 2017
Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients with Painful Bone Metastases: An Iranian Patient's Perspective StudyYahya Bayazidi, Ali Keshtkaran, Enayatollah Homaie Rad, et al.Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|November 17, 2022
Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020Fatemeh Kokabisaghi, Amir Hashemi-Meshkini, Asaad Obewal, et al.Journal of Research in Pharmacy Practice|August 12, 2016
Pharmaceutical laws and regulations in Iran: An overviewPardis Zaboli, Amir Hashemi-Meshkini, Mehdi Varmaghani, et al.Archives of Iranian Medicine|February 4, 2016
Wealth-related Inequality in Utilization of Antihypertensive Medicines in Iran: an Ecological Study on Population Level DataAmir Hashemi-Meshkini, Abbas Kebriaeezadeh, Hamidreza Jamshidi, et al.Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|October 27, 2017
Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trialsKhosro Keshavarz, Farhad Lotfi, Ehsan Sanati, et al.Pageof 3